Your browser doesn't support javascript.
[Potential antiviral therapeutics for 2019 Novel Coronavirus].
Li, H; Wang, Y M; Xu, J Y; Cao, B.
  • Li H; Center of Respiratory Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100020, China.
  • Wang YM; Center of Respiratory Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100020, China.
  • Xu JY; Department of Basic Medical Sciences, Tsinghua University School of Medicine, Beijing 100084, China.
  • Cao B; Center of Respiratory Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100020, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 43(0): E002, 2020 Feb 05.
Article in Chinese | MEDLINE | ID: covidwho-309
ABSTRACT
The recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-ß, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: Chinese Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2020 Document Type: Article Affiliation country: Cma.j.issn.1001-0939.2020.0002

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: Chinese Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2020 Document Type: Article Affiliation country: Cma.j.issn.1001-0939.2020.0002